Ets Variant 5 (ETV5) Peptide
ETV5
适用: 人
宿主: 合成
BP, WB
-
- 抗原 See all ETV5 products
- ETV5 (Ets Variant 5 (ETV5))
- 宿主
- 人
-
资源
- 合成
- 应用范围
- Blocking Peptide (BP), Western Blotting (WB)
- 产品特性
- This is a synthetic peptide designed for use in combination with anti-ETV5 antibody (Catalog #: ARP38468_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- 纯化方法
- Purified
-
-
- 应用备注
- Each Investigator should determine their own optimal working dilution for specific applications.
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 溶解方式
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- 浓度
- 1 mg/mL
- 缓冲液
- Final peptide concentration is 1 mg/mL in PBS.
- 注意事项
- Avoid repeated freeze-thaw cycles.
- 储存条件
- -20 °C
- 储存方法
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- 抗原
- ETV5 (Ets Variant 5 (ETV5))
- 别名
- ERM Peptide, etv5 Peptide, fj87h10 Peptide, id:ibd5133 Peptide, wu:fj87h10 Peptide, zgc:55647 Peptide, 1110005E01Rik Peptide, 8430401F14Rik Peptide, ETS variant 5 Peptide, ets variant 5 Peptide, ets variant 5a Peptide, ETV5 Peptide, Etv5 Peptide, etv5a Peptide
- 背景
-
ETV5 Contains 1 ETS DNA-binding domain and belongs to the ETS family. The ETV5 gene expression is regulated by the conventional PKC (cPKC) pathway.ETV5 is subject to SUMO modification and this post-translational modification causes inhibition of transcription-enhancing activity Phosphorylated ETV5 and the actin cytoskeleton regulate CD44-mediated hyaluronan binding in myeloid cells. ERMs (ezrin/radixin/moesin) function as adaptor molecules in the interactions of adhesion receptors and intracellular tyrosine kinases. ETV5 can cooperate with c-Jun and has a role in progression of breast cancer.
Alias Symbols: ERM
Protein Interaction Partner: AR,AR
Protein Size: 510 - 分子量
- 58 kDa
- 基因ID
- 2119
- NCBI登录号
- NM_004454, NP_004445
- UniProt
- P41161
-
You are here:
